SCHEMBL31735293

SCHEMBL31735293

COc1ccc(CN(c2cccc(F)n2)S(=O)(=O)c2c(C)cc(F)c(Cl)c2F)c(OC)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
SMN1; SMN2 Q16637 4/20 0.36
ALDH1A1 P00352 4/20 0.36
HTT P42858 1/20 0.36
KDM4E B2RXH2 3/20 0.35
OXTR P30559 2/20 0.33
KEAP1 Q14145 2/20 0.33
TP53 P04637 2/20 0.32
POLB P06746 1/20 0.32
LMNA P02545 2/20 0.32
TSHR P16473 2/20 0.32
CYP1A2 P05177 1/20 0.32
GLA P06280 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31566459 0.93 KDM4E (0.35) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL31735201 0.92 KDM4E (0.35) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL31735279 0.86 KMT2A (0.35) MEN1KMT2ASMN1; SMN2ALDH1A1TP53
SCHEMBL31735378 0.86 MEN1 (0.33) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL31735220 0.85 MEN1 (0.34) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL20238565 0.84 KMT2A (0.37) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL29669086 0.84 KMT2A (0.37) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL19631905 0.82 KMT2A (0.35) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL19614107 0.82 DHFR (0.35) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL19614108 0.82 KDM4E (0.36) MEN1KMT2ASMN1; SMN2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025245351-A1 SUBSTITUTED ARYL SULFONAMIDES AND COMPOSITIONS AND USES THEREOF XENON PHARMACEUTICALS INC. (CA) 2025-11-27 WO disclosed